ENA Welcomes Kurin to 2023 Corporate Engagement Council
March 7, 2023 • Corporate Engagement Council Emergency Nurses Association
Council fosters partnership between emergency nursing community and industry leaders
SCHAUMBURG, Ill. (March. 7, 2023) – The Emergency Nurses Association on Tuesday announced its 2023 Corporate Engagement Council, which includes Kurin, Inc., as its newest member.
Created in 2019, the CEC brings ENA and industry leaders together with a focus on innovation and advances in emergency nursing education, advocacy and research. Council members also participate in dedicated sessions with ENA Board members and leaders centered on discussion of, and planning for, future initiatives to advance emergency nursing.
The 2023 Corporate Engagement Council includes: Bioexcel Therapeutics, BrainScope, Chamberlain University, Elsevier, HealthStream, Magnolia, Mednition, Stryker, Teleflex and now Kurin.
“ENA prides itself on having a strong relationship with industry partners who deeply value emergency nurses and the ways they provide care to patients,” said ENA President Terry Foster, MSN, RN, CEN, CPEN, CCRN, TCRN, FAEN. “Kurin’s emphasis on innovative, clinician-approved technologies makes it a great addition to the CEC.”
Kurin CEO Bob Rogers described a natural connection between Kurin and ENA, which he called a vital organization that provides leadership and a wide variety of resources to emergency department nurses.
“We are pleased to have received the invitation from the ENA to join its council,” Rogers said. “Kurin has become the market leader by providing an easy-to-use solution to reduce blood culture contamination and our goal is to work with the ENA to help their members improve clinical outcomes.”
For more information on ENA’s Corporate Engagement Council, visit ena.org/corporate-support/cec.
###
About Kurin
Kurin, Inc., a certified Minority Business Enterprise (MBE), is focused on the design, development, manufacture, marketing, and sale of products that help healthcare providers reduce contaminated blood cultures. Kurin, manufactured in San Diego, California, has received FDA 510(k) market clearance. For more information about Kurin, visit the website at www.kurin.com.
